Skip directly to content


Inspra™ is an adjunct to standard therapy suitable for two types of heart failure patient: 1) patient with NYHA class II (chronic) heart failure; 2) patient with heart failure after recent myocardial infarction, which may effectively reduce the risk of cardiovascular mortality and hospitalization1.



1. Inspra™ (eplerenone) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version August 2017.


[PP-CPF-HKG-0067] SEP 2019